cleveland, March 7, 2024 /PRNewswire/ — BIOHM Health Inc., a leading innovator and patent holder of microbiome-based products and ingredients, announces a partnership with. Virginia Tech The use of artificial intelligence (AI) further powers the pioneering Symbiont™ platform. Peer-reviewed in gastroenterology, Symbiont is a process to identify and select ingredients that address bacterial and fungal dysbiosis in targeted cohorts as revealed in BIOHM's proprietary dataset. BIOHM's dataset is one of the largest in the world, combining bacterial and fungal genetic sequencing with more than 50 metadata points. This collaboration represents an important step forward in the development and commercialization of symptom-specific nutritional supplements based on a more complete understanding of the microbiome. Symbiont is expected to revolutionize the product formulation process, enabling thousands of iterations to quickly optimize ingredient selection for nutraceuticals.
“In navigating the complex web of microbiome influences on our health and longevity, this important effort will advance our ability to develop innovative and effective ingredients aimed at addressing critical health challenges. “It will promote and strengthen the economy,” he said. Sam SchatzCEO of BIOHM Health.
BIOHM Health Inc. is known for its groundbreaking work in microbiome research, leveraging its datasets to develop the next generation of targeted microbiome-based products. Currently, most products targeting the microbiome focus solely on bacteria, but in reality, fungi are an equally important component of the microbiome. With a mission to unlock the potential of the microbiome, the company is committed to leveraging cutting-edge technology to address major health challenges. “We believe that the microbiome is central to human health, and Symbiont intends to hone our formulations more precisely to target the microorganisms that cause dysbiosis,” said Dr. Ta. Mahmoud GhanoumChief Scientific Officer of BIOHM Health and Director of the Center for Medical Mycology Case Western Reserve University.
partnership with Virginia Tech will focus on accelerating the capabilities of BIOHM's Symbiont platform through the development of predictors using cutting-edge machine learning algorithms. These predictors associate microbial populations with specific phenotypes and enable the extraction of features for biomarker identification. By harnessing the power of deep machine learning, BIOHM aims to accelerate the discovery of new ingredients and formulations with targeted health benefits.
In addition to machine learning, Symbiot incorporates intelligent search capabilities to analyze public data sources such as research publications, ingredient efficacy studies, patents, and clinical trials. This innovative approach allows for the identification of unique formulations that can modulate identified biomarkers in targeted cohorts, ultimately increasing the efficacy of nutraceuticals.
Dan Sui, Virginia Tech “Research collaborations with industry are key to driving innovative solutions and scientific advances that ultimately improve the human condition,” said the Senior Vice President of Research and Innovation. We are excited to leverage our knowledge and work closely with BIOHM.”
“Symbiont is a perfect example of VTC Venture’s philosophy of supporting innovative technology companies that can leverage our world-leading research capabilities. Virginia Tech,” Said brian mixer, Managing Director of VTC Ventures and Director of BIOHM. “We have been impressed with the BIOHM team’s progress since our investment and are excited to use AI to further accelerate their product development.”
Partnership with BIOHM Health Inc. Virginia Tech This represents a collaborative effort to push the boundaries of microbiome research and product development.
contact address:
sarah sullivan
Vice President of Marketing
Biome Health Co., Ltd.
[email protected]
(443) 562-3728
Lindsay A. Ho
Senior Director, Marketing and Communications
Virginia Tech | Research and Innovation
[email protected]
o: (540) 231-6959 | c: (540) 230-6230
About BIOHM Health Inc.: BIOHM Health Inc. is a leading innovator of microbiome-based products and ingredients, dedicated to improving human health by unlocking the potential of bacterial and fungal relationships in the microbiome. The company leverages cutting-edge technology and proprietary data sets to develop targeted solutions to major health challenges.
about Virginia Tech: Virginia Tech is a renowned research university committed to advancing knowledge and driving innovation across a variety of fields. The University strives to address complex societal challenges and improve the well-being of individuals and communities through collaborative partnerships and cutting-edge research.
Source Biome Health
